ProCE Banner Activity

PRIDOX: DoxyPEP for Men Who Have Sex With Men at High Risk for Sexually Transmitted Infections

Conference Coverage
Slideset

In this real-world analysis, DoxyPEP significantly reduced chlamydia, gonorrhea, and syphilis incidence among PrEP users at high risk for STIs.

Released: November 22, 2024

Expiration: November 21, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare